Repositório Digital de Publicações Científicas: Innovative Medicines: An Analysis of EMA Approvals from the Perspective of Active Substances

Please use this identifier to cite or link to this item: http://hdl.handle.net/10174/41146

Title:	Innovative Medicines: An Analysis of EMA Approvals from the Perspective of Active Substances
Authors:	Costa, Paula Advinha, Ana Margarida Oliveira-Martins, Sofia
Issue Date:	2024
Citation:	Costa P, Advinha AM, Oliveira-Martins S. Innovative Medicines: An Analysis of EMA Approvals from the Perspective of Active Substances. In: Abstracts of the 5th Annual Summit of the Comprehensive Health Research Centre (CHRC). Évora, Portugal: Port J Public Health, 42(suppl2); 2024. pp.11.
Abstract:	Innovative Medicines: An Analysis of EMA Approvals from the Perspective of Active Substances
URI:	https://karger.com/pjp/article/42/Suppl.%202/1/916273/Book-of-abstracts-of-the-5th-CHRC-Annual-Summit http://hdl.handle.net/10174/41146
Type:	article
Appears in Collections:	DCMS - Artigos em Livros de Actas/Proceedings

Files in This Item:

File	Description	Size	Format
000542309.pdf		1.2 MB	Adobe PDF	View/Open